Evidence map›Paper›PMID 24255121›Full record

ArticlemBio2013

cor, a novel carbon monoxide resistance gene, is essential for Mycobacterium tuberculosis pathogenesis.

Vineetha M Zacharia, Paolo S Manzanillo, Vidhya R Nair, Denise K Marciano, Lisa N Kinch, Nick V Grishin, Jeffery S Cox, Michael U Shiloh

Open access · goldAbstract read
In one paragraph

Article in mBio, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Early processes in heme-based CO-sensing proteins.Frontiers in molecular biosciences · 2022
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Vineetha M ZachariaDepartment of Internal Medicine, University of Texas Southwestern Medical School, Dallas, Texas, USA.
Paolo S Manzanillo
Vidhya R Nair
Denise K Marciano
Lisa N Kinch
Nick V Grishin
Jeffery S Cox
Michael U Shiloh
The University of Texas Southwestern Medical Center · USUniversity of California, San Francisco · USSouthwestern Medical Center · US

Funding

The role of Listeria cyclic-di-AMP during infection and immunityP01AI063302 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PORTNOY, DANIEL A · 2004 to 2025
$45.5M
MOLECULAR MICROBIOLOGY TRAINING GRANTT32AI007520 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Julie K Pfeiffer · 1997 to 2026
$7.0M
Microbial Pathogenesis and Host DefenseT32AI060537 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joanne N. Engel · 2004 to 2026
$6.5M
Regulation of ESX-1 secretion and its role in M. tuberculosis virulenceR01AI081727 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COX, JEFFERY S · 2010 to 2014
$2.0M
Carbon monoxide resistance in Mycobacterium tuberculosis pathogenesisR01AI099439 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI SHILOH, MICHAEL · 2012 to 2016
$2.0M
The Role of p120 Catenin in Metanephric Kidney DevelopmentK08DK081668 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MARCIANO, DENISE K · 2008 to 2012
$719k
Carbon monoxide in Mycobacterium tuberculosis pathogenesisK08AI076632 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI SHILOH, MICHAEL · 2008 to 2010
$365k
Regulation of ESX-1 secretion and its role in M. tuberculosis virulenceR56AI081727 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COX, JEFFERY S · 2009 to 2009
$355k
Howard Hughes Medical InstituteNIAID NIH HHS 5T32AI007520NIAID NIH HHS AI076632NIAID NIH HHS AI081727NIAID NIH HHS AI099439NIAID NIH HHS K08 AI076632NIAID NIH HHS P01 AI063302NIAID NIH HHS R01 AI081727NIAID NIH HHS R01 AI099439NIAID NIH HHS R56 AI081727NIAID NIH HHS T32 AI007520NIAID NIH HHS T32 AI060537NIDDK NIH HHS DK081668NIDDK NIH HHS K08 DK081668
6 · The paper itself

Abstract

unlabelledTuberculosis, caused by Mycobacterium tuberculosis, remains a devastating human infectious disease, causing two million deaths annually. We previously demonstrated that M. tuberculosis induces an enzyme, heme oxygenase (HO1), that produces carbon monoxide (CO) gas and that M. tuberculosis adapts its transcriptome during CO exposure. We now demonstrate that M. tuberculosis carries a novel resistance gene to combat CO toxicity. We screened an M. tuberculosis transposon library for CO-susceptible mutants and found that disruption of Rv1829 (carbon monoxide resistance, Cor) leads to marked CO sensitivity. Heterologous expression of Cor in Escherichia coli rescued it from CO toxicity. Importantly, the virulence of the cor mutant is attenuated in a mouse model of tuberculosis. Thus, Cor is necessary and sufficient to protect bacteria from host-derived CO. Taken together, this represents the first report of a role for HO1-derived CO in controlling infection of an intracellular pathogen and the first identification of a CO resistance gene in a pathogenic organism. IMPORTANCE: Macrophages produce a variety of antimicrobial molecules, including nitric oxide (NO), hydrogen peroxide (H2O2), and acid (H+), that serve to kill engulfed bacteria. In addition to these molecules, human and mouse macrophages also produce carbon monoxide (CO) gas by the heme oxygenase (HO1) enzyme. We observed that, in contrast to other bacteria, mycobacteria are resistant to CO, suggesting that this might be an evolutionary adaptation of mycobacteria for survival within macrophages. We screened a panel of ~2,500 M. tuberculosis mutants to determine which genes are required for survival of M. tuberculosis in the presence of CO. Within this panel, we identified one such gene, cor, that specifically confers CO resistance. Importantly, we found that the ability of M. tuberculosis cells carrying a mutated copy of this gene to cause tuberculosis in a mouse disease model is significantly attenuated. This indicates that CO resistance is essential for mycobacterial survival in vivo.

Indexed as

Drug Resistance, BacterialAnimalsAnti-Bacterial AgentsBacterial LoadCarbon MonoxideDisease Models, AnimalDNA Transposable ElementsEscherichia coliGene ExpressionMiceMice, Inbred BALB CMutagenesis, InsertionalMycobacterium tuberculosisSurvival AnalysisTuberculosisVirulenceAnti-Bacterial AgentsCarbon MonoxideDNA Transposable ElementsVirulence Factors

Identifiers

PMID24255121
PMCPMC3870250
OpenAlexW2126078646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.